Trial Profile
Long-term outcomes of OK 432 treatment in patients with lymphatic malformations
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2016
Price :
$35
*
At a glance
- Drugs Picibanil (Primary)
- Indications Lymphangioma
- Focus Therapeutic Use
- 16 Oct 2016 New trial record